Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/1998
03/12/1998WO1998009657A2 Method for recombinant adeno-associated virus-directed gene therapy
03/12/1998WO1998009656A1 Method for tolerizing a mammalian patient to administration of gene therapy virus vectors
03/12/1998WO1998009655A1 Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene
03/12/1998WO1998009649A1 Inhibition of viral replication
03/12/1998WO1998009614A1 Hydrogel base permeable device containing live cells, and its applications
03/12/1998WO1998009524A1 Methods and compositions for liver specific delivery of therapeutic molecules using recombinant aav vectors
03/12/1998WO1998004709A3 Herpes simplex virus ICP4 is an inhibitor of apoptosis
03/12/1998WO1998004585A3 Novel human macrophage antigen
03/12/1998WO1998001563A3 Adenovirus e4 proteins for inducing cell death
03/12/1998WO1998001161A3 Gene therapy delivery system for targeting to endothelia
03/12/1998WO1997049827A3 Adenoviral mediated gene transfer in adipocytes and related implants
03/12/1998WO1997046682A3 Polynucleotides from human adult PBMC encoding secreted proteins
03/12/1998WO1997038087A3 Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
03/12/1998CA2718347A1 Gene therapy for congestive heart failure
03/12/1998CA2264956A1 Herpesvirus saimiri as viral vector
03/12/1998CA2264924A1 Method for tolerizing a mammalian patient to administration of gene therapy virus vectors
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264499A1 Methods using cre-lox for production of recombinant adeno-associated viruses
03/12/1998CA2264485A1 Gata-6 transcription factor: compositions and methods
03/12/1998CA2264273A1 Human cns cell lines and methods of use therefor
03/11/1998EP0828005A2 Apoptotic agents for tumor cells of the nervous system
03/11/1998EP0828003A2 Human serine protease
03/11/1998EP0827547A1 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof
03/11/1998EP0827546A2 Gene therapy using replication competent targeted adenoviral vectors
03/11/1998EP0827545A2 Retroviral vectors
03/11/1998EP0827538A1 Novel variants of apolipoprotein a-i
03/11/1998EP0827536A1 A method for large scale plasmid purification
03/11/1998EP0827410A1 Method for introducing and expressing genes in animal cells
03/11/1998EP0827396A1 Production scale method of forming microparticles
03/11/1998EP0759070A4 Blood-borne mesenchymal cells
03/11/1998EP0710279A4 Yolk sac stem cells and their uses
03/10/1998US5726160 Treatment of diseases such as cystic fibrosis, emphysema, bronchitis and sinusitis
03/10/1998US5726027 Method for treatment of insulin resistance
03/10/1998US5726020 Inhibition of II synthesis
03/10/1998US5725854 Administering cells and immunology
03/06/1998CA2209890A1 Apoptotic agents for tumor cells of the nervous system
03/05/1998WO1998009170A2 Methods and compositions for the detection of cervical cancer
03/05/1998WO1998008974A2 Catalytic nucleic acid and its medical use
03/05/1998WO1998008965A2 Cd95 regulatory gene sequences and transcription factors
03/05/1998WO1998008964A1 Mammalian artificial chromosomes
03/05/1998WO1998008956A2 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998WO1998008955A1 Stimulus-inducible i (kappa)b kinase [ikk] signalsome
03/05/1998WO1998008953A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998WO1998008947A1 Enhancement of dna immunization through the use of cytokines
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008863A1 Enzyme and dna sequence encoding same
03/05/1998WO1998008859A1 Bioconjugates and delivery of bioactive agents
03/05/1998WO1998008542A2 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998WO1998008541A1 Inhibition of primary and/or secondary immune response to repeat adenoviral vector administration using cd40l specific antibodies
03/05/1998WO1998008489A1 Cationic lipid-nucleic acid complexes
03/05/1998WO1998008375A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
03/05/1998WO1998002548A3 Infectious papillomavirus pseudoviral particles
03/05/1998WO1998001554A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1998001160A3 Compositions suitable for delivery of genes to epithelial cells
03/05/1998WO1997044474A3 Viral particles which are masked or unmasked with respect to a cell receptor
03/05/1998WO1997030731A3 Method of preparing polynucleotide-carrier complexes for delivery to cells
03/05/1998CA2265088A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998CA2264571A1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid
03/05/1998CA2264246A1 Catalytic nucleic acid and its medical use
03/05/1998CA2264140A1 Cationic lipid-nucleic acid complexes
03/05/1998CA2263951A1 Use of a mutated macrolide binding protein for the prevention of gvhd
03/05/1998CA2263885A1 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263824A1 Cd95 regulatory gene sequences and transcription factors
03/05/1998CA2259151A1 Enzyme and dna sequence encoding same
03/05/1998CA2194256A1 Ikaros: a t cell pathway regulatory gene
03/04/1998EP0826775A1 Vector system for conditional gene expression
03/04/1998EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase
03/04/1998EP0826063A1 Single-vial formulations of dna/lipid complexes
03/04/1998EP0826062A1 Hbv vectors and cells for producing the same
03/04/1998EP0826048A1 Pancreas-derived serpin
03/04/1998EP0826045A1 Nucleic acids for treating obesity
03/04/1998EP0826043A1 Methods for modulating t cell survival by modulating bcl-x l? protein level
03/04/1998EP0826042A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
03/04/1998EP0826041A1 Transforming growth factor alpha hii
03/04/1998EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
03/04/1998EP0825875A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
03/04/1998EP0825873A2 Anticancer vaccine comprising il6/il6 receptor transfected cells
03/03/1998US5723333 Vectors of oncogenes, promoters, transcription
03/03/1998US5723315 Secreted proteins and polynucleotides encoding them
03/03/1998US5723313 ARF-p19, a novel regulator of the mammalian cell cycle
03/03/1998US5723311 Human DNA topoisomerase I α
03/03/1998US5723290 Methods for profiling mRNA expression in neurites
03/03/1998US5723287 Retroviral particle comprising fusion protein and nucleic acid; genetic engineering
02/1998
02/26/1998WO1998008090A1 Anti-idiotypic antibodies to an epiglycanin
02/26/1998WO1998007878A2 Long-term expression of gene products by transforming muscle cells
02/26/1998WO1998007877A1 A short-shafted adenoviral fiber and its use
02/26/1998WO1998007876A2 Self-replicating episomal expression vectors conferring tissue-specific gene expression
02/26/1998WO1998007874A2 New systems for regulating genetic expression
02/26/1998WO1998007865A1 Targeting adenovirus with use of constrained peptide motifs
02/26/1998WO1998007864A1 Recombinant toxin fragments
02/26/1998WO1998007859A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007855A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007854A1 Human glycine transporter
02/26/1998WO1998007850A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
02/26/1998WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
02/26/1998WO1998007833A1 Compositions and methods for use of defensin
02/26/1998WO1998007832A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
02/26/1998WO1998007829A8 Use of flexible plastic tanks in gene theraphy
02/26/1998WO1998007829A2 Use of flexible plastic tanks in gene theraphy
1 ... 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 ... 870